Press Releases

• All News
• 2020
• 2019
• 2018
• 2017
• 2016
• 2015
• 2014
• 2013
• 2012
• 2011

Feb 20, 2020 • 4:10 PM EST VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update

Feb 18, 2020 • 4:10 PM EST VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update

Feb 18, 2020 • 8:30 AM EST Volition Unveils Its Epigenetic Toolbox

Feb 7, 2020 • 5:30 PM EST VolitionRx Announces Filing of Registration Statements

Jan 13, 2020 • 9:00 AM EST Volition Develops a New Improved Nu.Q™ Assay Format

Jan 10, 2020 • 8:00 AM EST VolitionRx Completes Acquisition of Octamer GmbH

Dec 16, 2019 • 8:30 AM EST VolitionRx Limited Announces Strategic Acquisition

Dec 5, 2019 • 8:30 AM EST VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test

Dec 3, 2019 • 8:30 AM EST VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia

Nov 13, 2019 • 3:54 AM EST VolitionRx Limited Announces Third Quarter 2019 Financial Results and Business Update

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• ...23
• Next »